Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 4
Submit an article Journal homepage
1,798
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia

Yaneth Gil-Rojasa Department of Economic Studies, Neuroeconomix, Bogota, ColombiaView further author information
,
Pieralessandro Lasalviaa Department of Economic Studies, Neuroeconomix, Bogota, ColombiaCorrespondence[email protected]
View further author information
&
Ángel Garcíab Cardiology Unit, San Ignacio University Hospital, Pontificia Universidad Javeriana, Bogotá, ColombiaView further author information
Pages 655-663 | Received 18 Jun 2021, Accepted 20 Oct 2021, Published online: 16 Nov 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.